Sponsor

Institut Pasteur

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Institut Pasteur appears in 25 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials25
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

25 shown
Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MINDNCT07205913 · lead sponsor · 2026-02-15
NOT_YET_RECRUITING
Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in VietnamNCT05506475 · lead sponsor · 2024-05-01
UNKNOWN
MOVIDA 1 Ter - Evaluation of the Cobas® Plasma Separation Card in the Field in VietnamNCT04794725 · lead sponsor · 2022-10-05
COMPLETED
Cellular microRNA Signatures in Multiple SclerosisNCT05290688 · lead sponsor · 2022-09-15
UNKNOWN
Role of Nasal Dysbiosis in Parkinson DiseaseNCT04249245 · lead sponsor · 2020-02-14
COMPLETED
Evaluation of Hepatitis C Viral Load Quantification on DBS in VietnamNCT03670251 · lead sponsor · 2019-05-09
COMPLETED
Monitoring Of Viral Load In Decentralised Area in VietnamNCT03249493 · lead sponsor · 2017-08-15
COMPLETED
A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of RelapseNCT02364492 · lead sponsor · 2015-02-01
COMPLETED
Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium FalciparumNCT01746199 · lead sponsor · 2013-12-01
COMPLETED
Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV VaccineNCT01320176 · lead sponsor · 2010-10-01
COMPLETED
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)NCT07170748 · collaborator · 2025-07-29
RECRUITING
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlNCT05300035 · collaborator · 2024-04-11
RECRUITING
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)NCT07692295 · collaborator · 2026-10-01
NOT_YET_RECRUITING
Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III CohortNCT07770568 · collaborator · 2026-08-01
NOT_YET_RECRUITING
MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR CongoNCT07388979 · collaborator · 2026-03-01
NOT_YET_RECRUITING
Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological MechanismsNCT06302933 · collaborator · 2024-05-02
UNKNOWN
The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)NCT05951751 · collaborator · 2024-03-18
UNKNOWN
Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNCT05922735 · collaborator · 2023-09-01
UNKNOWN
Baromètre Santé Adulte 2021-2022NCT05218304 · collaborator · 2021-07-26
SUSPENDED
ANRS 12406 EvvA StudyNCT04593979 · collaborator · 2021-04-15
UNKNOWN
Driving Reduced AIDS-associated Meningo-encephalitis MortalityNCT03226379 · collaborator · 2016-04-23
COMPLETED
Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan AfricaNCT01715922 · collaborator · 2012-05-01
UNKNOWN
Prolactin Receptor and Breast DiseasesNCT00842465 · collaborator · 2008-09-01
COMPLETED
Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM ProjectNCT02043418 · collaborator · 2007-11-01
ACTIVE_NOT_RECRUITING
Immunology of the Infection PerinatalNCT01055873 · collaborator · 2007-02-01
COMPLETED

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Institut Pasteur as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
fluconazole1
flucytosine1
placebo1

Sponsor roles

collaborator15
lead sponsor10
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.